Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004

Diagnostic Microbiology and Infectious Disease
Wonkeun SongKyu Man Lee

Abstract

The aim of the study is to investigate the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae naturally lacking chromosomal AmpC beta-lactamases. A total of 1860 clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis were collected from a Korean hospital between January 2002 and December 2004. For the isolates that are nonsusceptible to cefoxitin, polymerase chain reaction amplification of the bla(SHV), bla(TEM), and bla(AmpC) genes and sequencing were performed. Plasmid-mediated AmpC beta-lactamases were found in 2.9% (37 isolates of DHA-1, 1 isolate of CMY-1, 1 isolate of CMY-2, and 1 isolate of ACT-1) of Klebsiella pneumoniae, 2.5% (5 isolates of DHA-1) of Klebsiella oxytoca, 0.8% (1 isolate of DHA-1) of Salmonella spp., and none of P. mirabilis isolates. The DHA-1-producing K. pneumoniae was only 2 isolates (0.6%) in 2002, but the rate and the number significantly increased to 2.4% (13 of 538 isolates) in 2003 and to 4.3% (22 of 512) in 2004. In conclusion, DHA-1 is the most prevalent plasmid-mediated AmpC beta-lactamase in Enterobacteriaceae lacking chromosomal ampC gene, and the DHA-1-producing K. pneumoniae isolates have rapidly increased since 2003 in a Korean hospital. In ad...Continue Reading

References

Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E SandersR E Kessler
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Alain PhilipponGeorge A Jacoby
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Mark D Reisbig, Nancy D Hanson
May 31, 2002·Journal of Clinical Microbiology·F Javier Pérez-Pérez, Nancy D Hanson
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·M AlvarezG A Jacoby
Oct 16, 2004·The Journal of Antimicrobial Chemotherapy·Cheol-In KangKang-Won Choe
Sep 8, 2005·Journal of Clinical Microbiology·Wonkeun SongKenneth S Thomson

❮ Previous
Next ❯

Citations

May 2, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H DingX Shen
Sep 8, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E MiróF Navarro
Jul 14, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Joanna EmpelMarek Gniadkowski
Mar 19, 2011·The Journal of Antimicrobial Chemotherapy·Juwon KimKyungwon Lee
Jul 9, 2010·Journal of Clinical Microbiology·Katsutoshi YamasakiYoshimasa Yamamoto
Oct 8, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F FreitasL Peixe
Jul 31, 2007·Future Microbiology·Gian Maria Rossolini, Jean-Denis Docquier
Mar 20, 2009·International Journal of Antimicrobial Agents·Yoon Soo ParkHyunjoo Pai
Dec 20, 2008·International Journal of Antimicrobial Agents·Francesco LuzzaroAntonio Toniolo
Jun 16, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C MataF Navarro
Mar 28, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Min Kyeong ChaJae-Hoon Song
Mar 6, 2009·The Korean journal of laboratory medicine·Sungwook SongSeok Hoon Jeong
Aug 19, 2014·The Journal of Obstetrics and Gynaecology Research·Fatemeh AbdollahiMunn-Sann Lye
Jul 5, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Hye Sun HyunHee Gyung Kang
Apr 2, 2021·Frontiers in Cellular and Infection Microbiology·Susan RealegenoShangxin Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.